DNA Genotek buy takes OraSure into fast-growing molecular Dx segment
This article was originally published in Clinica
Executive Summary
Oral fluid diagnostics specialist OraSure Technologies has gained a foothold in the molecular diagnostics market by agreeing to acquire DNA Genotek for $53m in cash. OraSure estimates that the segment is worth $4bn, and is growing rapidly.